Chiesi signs $1.9B deal to acquire KalVista and its approved drug
Chiesi signs $1.9B deal to acquire KalVista and its approved drug
Body unavailable. Use the original source.
Chiesi signs $1.9B deal to acquire KalVista and its approved drug
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.